Follistatin is a novel therapeutic target and biomarker in <scp>FLT</scp> 3/ <scp>ITD</scp> acute myeloid leukemia
2020 · EMBO Molecular Medicine · 16 citations
https://doi.org/10.15252/emmm.201910895
N
Nelson Ka‐Lam Ng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Nelson Ka‐Lam Ng is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat